New Brain Therapy Cuts PTSD Symptoms by 52% in FDA Trial

A personalized brain therapy just cleared FDA approval after reducing PTSD symptoms by 52% and achieving 68% remission in clinical trials.

The breakthrough could help 13 million Americans struggling with post-traumatic stress disorder.